Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1988-11-03
1992-03-24
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Lymphokine
424 88, 424 858, 424 86, A61K 3929
Patent
active
050987046
ABSTRACT:
Vaccines are provided produced by hybrid DNA technology for Hepatitis B virus comprising Hepatitis B surface antigen particles containing a human polyalbumin binding site receptor. Constructs are provided for expression of the vaccine protein, which upon transformation in an appropriate host results in the production of particles useful as vaccines.
REFERENCES:
patent: 4741901 (1988-05-01), Levinson et al.
patent: 4769238 (1988-09-01), Ratter et al.
patent: 4778784 (1988-10-01), Dreasman et al.
patent: 4816564 (1989-03-01), Ellis et al.
patent: 4818527 (1989-04-01), Thornton et al.
patent: 4847080 (1989-07-01), Neurath et al.
patent: 4935235 (1990-06-01), Ratter et al.
Valenzuela, P., et al., Nature (1979) 280: 815-819.
Valenzuela, P., et al., Animal Virus Genetics (1980) pp. 57-70.
Thung, S. N., et al., Liver (1981) 1: 75-80.
Valenzuela, P., et al., Nature (1982) 298: 347-350.
Stibbe, W. et al., J. of Virol. (1983) 46(2): 626-628.
Machida, A., et al., Gastroenterology (1983) 85: 268-274.
Neurath, A. R. et al., Science (1984) 224: 392-395.
Machida, A., et al., Gastroenterology (1984) 86: 910-918.
Michel, M. L., et al., Int. Symp. on Viral Hepatitis, 1984.
Chiron Corporation
Draper Garnette D.
LandOfFree
Hepatitis surface antigen particle vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis surface antigen particle vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis surface antigen particle vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2008822